C

Cutia Therapeutics
HKEX:2487

Watchlist Manager
Cutia Therapeutics
HKEX:2487
Watchlist
Price: 6.1 HKD Market Closed
Market Cap: 2.2B HKD

Intrinsic Value

The intrinsic value of one Cutia Therapeutics stock under the Base Case scenario is hidden HKD. Compared to the current market price of 6.1 HKD, Cutia Therapeutics is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Cutia Therapeutics Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Cutia Therapeutics

Intrinsic Value History
Dive into the past to invest in the future

Cutia Therapeutics looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Cutia Therapeutics is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Cutia Therapeutics?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Cutia Therapeutics valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cutia Therapeutics.

Explain Valuation
Compare Cutia Therapeutics to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Cutia Therapeutics?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Cutia Therapeutics

Balance Sheet Decomposition
Cutia Therapeutics

Current Assets 822.5m
Cash & Short-Term Investments 681.5m
Receivables 38m
Other Current Assets 103m
Non-Current Assets 293.7m
PP&E 208m
Intangibles 8.4m
Other Non-Current Assets 77.3m
Current Liabilities 260m
Accounts Payable 51.2m
Short-Term Debt 122.4m
Other Current Liabilities 86.4m
Non-Current Liabilities 99.6m
Long-Term Debt 81.6m
Other Non-Current Liabilities 18m
Efficiency

Free Cash Flow Analysis
Cutia Therapeutics

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cutia Therapeutics

Revenue
250.3m CNY
Cost of Revenue
-125.1m CNY
Gross Profit
125.2m CNY
Operating Expenses
-601.2m CNY
Operating Income
-476m CNY
Other Expenses
3.7m CNY
Net Income
-472.3m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Cutia Therapeutics's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
hidden
Profitability
Score

Cutia Therapeutics's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Cutia Therapeutics's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
hidden
Solvency
Score

Cutia Therapeutics's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Cutia Therapeutics

Wall Street analysts forecast Cutia Therapeutics stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Cutia Therapeutics is 13.43 HKD with a low forecast of 9.4 HKD and a high forecast of 15.96 HKD.

Lowest
Price Target
9.4 HKD
54% Upside
Average
Price Target
13.43 HKD
120% Upside
Highest
Price Target
15.96 HKD
162% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cutia Therapeutics
does not pay dividends
Shareholder Yield

Current shareholder yield for Cutia Therapeutics is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Cutia Therapeutics stock?

The intrinsic value of one Cutia Therapeutics stock under the Base Case scenario is hidden HKD.

Is Cutia Therapeutics stock undervalued or overvalued?

Compared to the current market price of 6.1 HKD, Cutia Therapeutics is hidden .

Back to Top